课题基金 / 基金详情

Expression and Cellular Localization of Subunit Proteins of ATP-sensitive K+ Channels

Expression and Cellular Localization of Subunit Proteins of ATP-sensitive K+ Channels
ATP 敏感 K 通道亚基蛋白的表达和细胞定位
批准号:
11670675
负责人:
MURAKAMI Tomoyuki
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

MURAKAMI Tomoyuki的其他基金

相似基金

相关文献

中文摘要
翻译
心肌ATP敏感性钾<ATP>通道在预处理的心肌保护作用中起重要作用。表面通道被认为是由内向整流钾通道(Kir6.1和/或Kir6.2)亚基和磺酰脲受体(SUR 2A)组成的复合物。近年来,线粒体钾<ATP>通道作为一种重要的预适应效应器而受到关注,但其组成成分尚未明确。我们证明,长期心肌缺血特异性上调Kir6.1 mRNA及其蛋白不仅在缺血区域,而且在非缺血区域在大鼠心脏。相反,Kir6.2和SUR 2A的转录和蛋白水平保持不变。我们还发现,应力诱导的组织Ang II的释放是负责在心肌缺血心脏Kir6.1 mRNA和蛋白表达的特异性诱导。共聚焦显微镜检查显示Kir6.x和Kir6.1+ SUR 2A在COS 7细胞膜和胞浆中非特异性表达,而Kir6.x+ SUR 1和Kir6.2+ SUR 2A仅在膜中特异性表达。相反,Kir6.x+SURx的组合在线粒体中均不表达。本实验还研究了线粒体钾通道特异性开放剂二氮嗪<ATP>和非特异性开放剂克罗卡林<ATP>对家兔心肌的保护作用。Cromakalim,而不是二氮嗪,限制了心肌缺血引起的梗死面积。非特异性钾通道拮抗剂格列本脲<ATP>可抑制预处理的心肌梗死范围限制作用。这些研究表明,<ATP>由Kir6.2+ SUR 2A组成的表面钾通道在心肌保护中起重要作用。然而,Kir6.2/Kir6.1+ SUR 2A的潜在心脏保护作用需要进一步研究。
英文摘要
The cardiac ATP-sensitive potassium (K_<ATP>) channel plays a crucial role in the cardioprotection induced by preconditioning. The surface channel is thought to be a complex composed of an inward rectifier potassium channel (Kir6.1 and/or Kir6.2) subunit and the sulfonylurea receptor (SUR2A). Recently, although its composition has not yet been identified, the mitochondrial K_<ATP>channel has been paid attention as a key effector of preconditioning. We demonstrated prolonged myocardial ischemia specifically upregulated Kir6.1 mRNA and its protein not only in the ischemic region but also in the non-ischemic region in rat hearts. In contrast, transcriptional and protein levels for Kir6.2 and SUR2A remained unchanged. We also showed that stress-induced release of tissue Ang II is responsible for the specific induction of cardiac Kir6.1 mRNA and protein expression under myocardial ischemia. Confocal microscopic examination demonstrated Kir6.x and Kir6.1+SUR2A are non-specifically expressed in the membrane and cytosole of COS7 cells, while Kir6.x+SUR1 and Kir6.2+SUR2A are specifically expressed in the membrane alone. In contrast, none of combinations of Kir6.x+SURx are expressed in the mitochondria. We also studied the cardioprotective effects of diazoxide, a specific mitochondrial K_<ATP> channel opener, and cromakalim, a non-specific K_<ATP> channel opener in rabbits. Cromakalim, but not diazoxide, limited the infarct-size induced by prolonged myocardial ischemia. Moreover, glibenclamide, a non-specific K_<ATP> channel antagonist, inhibited the infarct-size limiting effect of preconditioning. These studies revealed that surface K_<ATP> channel composed of Kir6.2+SUR2A plays an important role in the cardioprotection. However, potential cardioprotective role of Kir6.2/Kir6.1+SUR2A needs further examination.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
Tomoyuki Murakami: "Angiotensin II Type 1 Recept blockade Abolishes Specific KATPChannel Gene Expression in Rats with Myocardial Ischemia."Journal of Molecular and Cellular Cardiology. Vol.32. 2239-2247 (2000)
Tomoyuki Murakami:“血管紧张素 II 1 型受体阻断消除了心肌缺血大鼠中特定的 KATP 通道基因表达。”分子与细胞心脏病学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tomoyuki Murakami: "Novel Extracorporeal Granulocyte Apheresis Column Inhibits Myocardial Reperfusion Injury : Future Clinical Applications"Journal of Cardilology. 32. 321-329 (2000)
Tomoyuki Murakami:“新型体外粒细胞单采柱抑制心肌再灌注损伤:未来的临床应用”心脏病学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tomoyuki Murakami: "Angiotensin II Type 1 Receptor blockadeAbolishes Specific K_<ATP> Channel Gene Expression in Rats with Myocardial Ischemia"Journal of Mollecular and Cellular Cardiology. 32. 2239-2247 (2000)
Tomoyuki Murakami:“血管紧张素 II 1 型受体阻断消除了心肌缺血大鼠中特定的 K_<ATP> 通道基因表达”分子和细胞心脏病学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tomoyuki Murakami: "Novel Extracorporeal Granulocyte Apheresis Column Inhibits Myocardial Reperfusion Injury : Future Clinical applications"Journal of Cardiology. Vol.32. 321-329 (2000)
Tomoyuki Murakami:“新型体外粒细胞单采柱抑制心肌再灌注损伤:未来的临床应用”心脏病学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
6
    Regulation of ATP-sensitive K^+ channel gene expression in myocardial ischemia
    • 批准号:
      09670713
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.98万
    • 财政年份:
      1997
    • 负责人:
      MURAKAMI Tomoyuki
    • 依托单位:
    国内基金
    海外基金
    PEITC 去 甲 基 化 激 活 恶 性 胶 质 瘤 细 胞 中MiR-135a-Mitochondria 凋亡通路的机制研究
    • 批准号:
      2019JJ50542
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2019
    • 负责人:
      张陶蓝
    • 依托单位: